Shopping Cart 0
Cart Subtotal
USD 0

Arix Bioscience PLC (ARIX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Arix Bioscience PLC (Arix Bioscience), formerly Arix Bioscience Ltd, is a healthcare and life science company. It offers financing and operational and strategic direction for the companies to support their businesses. The company's expertise spans in various areas which include academic science, clinical and commercial strategy, company operations, venture capital, mergers and acquisitions and corporate finance. Arix Bioscience works in collaboration with universities in the UK, Europe and Australia for providing direct access to the innovative new technologies. It offers its services to both public and private sector companies. The company also has an operational presence in New York, the US. Arix Bioscience is headquartered in London, the UK.

Arix Bioscience PLC (ARIX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Artios Pharma Raises USD33.2 Million in Series A Financing 11

OptiKira Raises Funds through Venture Financing 12

Partnerships 12

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12

Equity Offering 14

Arix Bioscience Completes Underwriter's Exercise of Over-Allotment Option of IPO for USD16 Million 14

Verona Pharma Raises USD63 Million in Private Placement of Units 15

Arix Bioscience PLC-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Artios Pharma Raises USD33.2 Million in Series A Financing 11

OptiKira Raises Funds through Venture Financing 12

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12

Arix Bioscience Completes Underwriter's Exercise of Over-Allotment Option of IPO for USD16 Million 14

Verona Pharma Raises USD63 Million in Private Placement of Units 15

Arix Bioscience PLC, Key Competitors 18

Arix Bioscience PLC, Key Employees 19

Arix Bioscience PLC, Other Locations 20

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Arix Bioscience PLC (Arix Bioscience), formerly Arix Bioscience Ltd, is a healthcare and life science company. It offers financing and operational and strategic direction for the companies to support their businesses. The company's expertise spans in various areas which include academic science, clinical and commercial strategy, company operations, venture capital, mergers and acquisitions and corporate finance. Arix Bioscience works in collaboration with universities in the UK, Europe and Australia for providing direct access to the innovative new technologies. It offers its services to both public and private sector companies. The company also has an operational presence in New York, the US. Arix Bioscience is headquartered in London, the UK.

Arix Bioscience PLC (ARIX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Artios Pharma Raises USD33.2 Million in Series A Financing 11

OptiKira Raises Funds through Venture Financing 12

Partnerships 12

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12

Equity Offering 14

Arix Bioscience Completes Underwriter's Exercise of Over-Allotment Option of IPO for USD16 Million 14

Verona Pharma Raises USD63 Million in Private Placement of Units 15

Arix Bioscience PLC-Key Competitors 18

Key Employees 19

Locations And Subsidiaries 20

Head Office 20

Other Locations & Subsidiaries 20

Appendix 21

Methodology 21

About GlobalData 21

Contact Us 21

Disclaimer 21


List Of Figure

List of Figures

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9


List Of Table

List of Tables

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Key Facts, 2016 1

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5

Arix Bioscience PLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7

Arix Bioscience PLC, Deals By Therapy Area, 2011 to YTD 2017 8

Arix Bioscience PLC, Medical Devices Deals, 2011 to YTD 2017 9

Arix Bioscience PLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Artios Pharma Raises USD33.2 Million in Series A Financing 11

OptiKira Raises Funds through Venture Financing 12

Arix Bioscience, Lead Discovery Center, Max Planck Innovation and University of Leeds Enter into Partnership 12

Arix Bioscience Completes Underwriter's Exercise of Over-Allotment Option of IPO for USD16 Million 14

Verona Pharma Raises USD63 Million in Private Placement of Units 15

Arix Bioscience PLC, Key Competitors 18

Arix Bioscience PLC, Key Employees 19

Arix Bioscience PLC, Other Locations 20

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com